Yunnan Baiyao Group Co.,Ltd (SHE:000538)
57.11
-0.82 (-1.42%)
Sep 24, 2025, 9:45 AM CST
SHE:000538 Revenue
Yunnan Baiyao Group Co.,Ltd had revenue of 10.42B CNY in the quarter ending June 30, 2025, with 7.59% growth. This brings the company's revenue in the last twelve months to 40.84B, up 4.02% year-over-year. In the year 2024, Yunnan Baiyao Group Co.,Ltd had annual revenue of 40.03B with 2.36% growth.
Revenue (ttm)
40.84B
Revenue Growth
+4.02%
P/S Ratio
2.53
Revenue / Employee
4.40M
Employees
9,277
Market Cap
103.36B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 40.03B | 922.01M | 2.36% |
Dec 31, 2023 | 39.11B | 2.62B | 7.19% |
Jan 1, 2023 | 36.49B | 114.45M | 0.31% |
Jan 1, 2022 | 36.37B | 3.63B | 11.09% |
Dec 31, 2020 | 32.74B | 3.08B | 10.38% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jan 1, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 30.15B |
WuXi AppTec | 41.90B |
Shenzhen Mindray Bio-Medical Electronics | 32.94B |
Sichuan Biokin Pharmaceutical | 441.19M |
Shanghai United Imaging Healthcare | 10.98B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.52B |
Aier Eye Hospital Group | 21.94B |
Shanghai Fosun Pharmaceutical (Group) | 40.12B |